G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $132 | -78.4% | 49,297 | -56.3% | 0.00% | -83.3% |
| Q4 2022 | $612 | -99.9% | 112,746 | +34.0% | 0.01% | -47.8% |
| Q3 2022 | $1,051,000 | +373.4% | 84,119 | +87.1% | 0.02% | +283.3% |
| Q2 2022 | $222,000 | -62.2% | 44,964 | +37.9% | 0.01% | -64.7% |
| Q4 2020 | $587,000 | +90.0% | 32,607 | +22.0% | 0.02% | +30.8% |
| Q3 2020 | $309,000 | +13.2% | 26,732 | +411.4% | 0.01% | +85.7% |
| Q3 2018 | $273,000 | – | 5,227 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |